Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMC 174010)

Published in Infect Immun on May 01, 1996

Authors

J I Flock1, S A Hienz, A Heimdahl, T Schennings

Author Affiliations

1: Department of Microbiology, Immunology, Pathology, and Infectious Diseases, Karolinska Institutet, Huddinge University Hospital, Sweden. jifl@bimd01.hs.sll.se

Articles citing this

Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76

Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci U S A (2000) 3.46

Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun (1999) 2.28

Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun (2001) 1.89

Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun (2004) 1.83

A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J (2000) 1.82

Nucleator function of CsgB for the assembly of adhesive surface organelles in Escherichia coli. EMBO J (1997) 1.72

Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism. J Bacteriol (1997) 1.72

Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun (2006) 1.63

Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun (2002) 1.63

Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56

Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun (1997) 1.51

Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts. Infect Immun (2002) 1.33

Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates. J Clin Microbiol (1999) 1.20

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun (2001) 1.18

Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect Immun (2000) 1.18

Impact of the high-affinity proline permease gene (putP) on the virulence of Staphylococcus aureus in experimental endocarditis. Infect Immun (1999) 1.17

Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun (2002) 1.10

The fibronectin-binding proteins of Staphylococcus aureus may promote mammary gland colonization in a lactating mouse model of mastitis. Infect Immun (2003) 0.95

Shear stress prevents fibronectin binding protein-mediated Staphylococcus aureus adhesion to resting endothelial cells. Infect Immun (2001) 0.94

Bartonella henselae Pap31, an extracellular matrix adhesin, binds the fibronectin repeat III13 module. Infect Immun (2006) 0.92

Insertional inactivation of the gene for collagen-binding protein has a pleiotropic effect on the phenotype of Staphylococcus aureus. J Bacteriol (1996) 0.90

Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infect Immun (2010) 0.87

Staphylococcus aureus, Platelets, and the Heart. Curr Infect Dis Rep (2000) 0.87

Treponema pallidum subsp. pallidum TP0136 protein is heterogeneous among isolates and binds cellular and plasma fibronectin via its NH2-terminal end. PLoS Negl Trop Dis (2015) 0.79

Articles cited by this

Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol (1972) 8.33

Fibronectin binds to Staphylococcus aureus. Nature (1978) 4.39

Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A (1989) 3.94

Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65

Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol Microbiol (1995) 3.30

Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79

Natural history of aortic valve endocarditis in rats. Infect Immun (1982) 2.74

Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur J Biochem (1991) 2.71

Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun (1989) 2.36

Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08

Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun (1992) 2.03

Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99

Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect Immun (1987) 1.90

Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85

Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog (1992) 1.76

Identification and biochemical characterization of the ligand binding domain of the collagen adhesin from Staphylococcus aureus. Biochemistry (1993) 1.55

Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits. Proc Soc Exp Biol Med (1985) 1.50

Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog (1993) 1.40

Binding of elastin to Staphylococcus aureus. J Biol Chem (1991) 1.21

Binding of a Staphylococcus aureus bone pathogen to type I collagen. Microb Pathog (1990) 1.18

Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res (1982) 1.00

Evidence that the heparin-binding consensus sequence of vitronectin is recognized by Staphylococcus aureus. J Biochem (1994) 0.83

Articles by these authors

Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis (1996) 1.94

Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis (1993) 1.92

Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis (1979) 1.61

Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother (1981) 1.52

Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun (1996) 1.46

Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog (1993) 1.40

Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med (1984) 1.34

The normal human anaerobic microflora. Scand J Infect Dis Suppl (1982) 1.33

Direct oral microscopy and its value in diagnosing mucosal lesions: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.32

Dental implant installation without antibiotic prophylaxis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.31

Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol (1980) 1.26

Microbial colonization of tumors in relation to the upper gastrointestinal tract in patients with gastric carcinoma. Ann Surg (1988) 1.03

Clinical appearance of orofacial infections of odontogenic origin in relation to microbiological findings. J Clin Microbiol (1985) 1.01

Pathological changes related to long-term impaction of third molars. A radiographic study. Int J Oral Maxillofac Surg (1989) 1.00

Influence of erythromycin on the normal human flora and colonization of the oral cavity, throat and colon. Scand J Infect Dis (1982) 0.94

Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis Suppl (1986) 0.94

Acanthomatous ameloblastoma. Int J Oral Surg (1980) 0.93

The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis (1984) 0.93

Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol (1982) 0.92

Effect of application of cold dressings on the postoperative course in oral surgery. Int J Oral Surg (1985) 0.92

Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet (1984) 0.91

Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis. J Antimicrob Chemother (1996) 0.90

Orofacial infections of odontogenic origin. Scand J Infect Dis Suppl (1983) 0.90

Detection of anaerobic bacteria in blood cultures by lysis filtration. Eur J Clin Microbiol (1985) 0.90

Human immunodeficiency virus type 1 and cytomegalovirus in saliva. J Med Virol (1993) 0.89

Effect of low level energy laser irradiation on wound healing. An experimental study in rats. Swed Dent J (1994) 0.88

Virulence factors of Staphylococcus aureus in the pathogenesis of endocarditis. A comparative study of clinical isolates. Zentralbl Bakteriol (1998) 0.87

Effect of chemotherapy on dental maturity in children with hematological malignancies. Pediatr Dent (1989) 0.86

The first 100 patients with jaw fractures at the Department of Oral Surgery, Dental School, Huddinge. Swed Dent J (1977) 0.86

Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis (1984) 0.86

Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis Suppl (1985) 0.86

Impact of orally administered antimicrobial agents on human oropharyngeal and colonic microflora. J Antimicrob Chemother (1986) 0.85

Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol (1988) 0.85

Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scand J Infect Dis (1987) 0.85

Changes in the oropharyngeal and colon microflora in relation to antimicrobial concentrations in saliva and faeces. Scand J Infect Dis Suppl (1985) 0.85

Effect of bacampicillin on human mouth, throat and colon flora. Infection (1979) 0.84

Development and characterization of a new model of hematogenous osteomyelitis in the rat. J Infect Dis (1995) 0.84

Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease. Clin Microbiol Infect (2004) 0.84

A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus. Arch Oral Biol (1992) 0.84

Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clin Infect Dis (1999) 0.84

Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations. Clin Exp Immunol (1988) 0.84

Oral condition of patients with leukemia and severe aplastic anemia. Follow-up 1 year after bone marrow transplantation. Oral Surg Oral Med Oral Pathol (1985) 0.83

Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. Eur J Clin Microbiol (1985) 0.83

Experimental mandibular Staphylococcus aureus osteomyelitis; antibody response and treatment with dicloxacillin. Int J Oral Maxillofac Surg (1986) 0.81

Facial growth and morphology in long-term survivors after bone marrow transplantation. Eur J Orthod (1989) 0.81

Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms. J Clin Periodontol (1991) 0.81

Changes in the protein composition of whole saliva during radiotherapy in patients with oral or pharyngeal cancer. Oral Surg Oral Med Oral Pathol (1986) 0.81

Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Eur J Clin Microbiol Infect Dis (1996) 0.81

Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections. Eur J Clin Microbiol Infect Dis (1992) 0.80

Evaluation of single-tooth restorations on ITI dental implants. A prospective study of 29 patients. Clin Oral Implants Res (1999) 0.79

Long-term results of amalgam versus glass ionomer cement as apical sealant after apicectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 0.79

Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis (1983) 0.79

Presence of autologous neutralizing antibodies against cytomegalovirus (CMV) in serum of human immunodeficiency virus type 1-infected patients shedding CMV in saliva. J Infect Dis (1994) 0.79

Brånemark System and ITI Dental Implant System for treatment of mandibular edentulism. A comparative randomized study: 3-year follow-up. Clin Oral Implants Res (2001) 0.79

Impact of different antimicrobial agents on the colonisation resistance in the intestinal tract with special reference to doxycycline. Scand J Infect Dis Suppl (1988) 0.78

Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med (1992) 0.78

Lip piercing: prevalence of associated gingival recession and contributing factors. A cross-sectional study. J Periodontal Res (2007) 0.78

Impact of different betalactam antibiotics on the normal human flora, and colonization of the oral cavity, throat and colon. Infection (1982) 0.78

Oropharyngeal colonisation with fungi and gram-negative rods in patients treated with radiotherapy of the head and neck. Br J Oral Maxillofac Surg (1989) 0.78

Occurrence of penicillin-resistant and beta-lactamase-producing Bacteroides species in the oral cavity. Scand J Gastroenterol Suppl (1984) 0.78

[Study on the formation of experimental infected rabbit]. Shigaku (1989) 0.78

Bone grafting to the maxillary sinus from the lateral side of the mandible. Br J Oral Maxillofac Surg (2000) 0.77

Effect of phenoxymethylpenicillin and erythromycin prophylaxis on anaerobic bacteraemia after oral surgery. J Antimicrob Chemother (1985) 0.77

Development and characterization of an animal model of dental sinusitis. Acta Otolaryngol (2005) 0.77

Fibronectin associated with infiltrating T lymphocytes. Evidence for in situ localization in biopsies and synthesis in vitro. Eur J Immunol (1991) 0.77

Variables predicting oral mucosal lesions in allogenic bone marrow recipients. Head Neck (1991) 0.77

Antimicrobial agents and the human oropharyngeal and intestinal microflora. Ann Ist Super Sanita (1986) 0.76

Effect of insertion of osseo-integrated prosthesis on the oral microflora. Swed Dent J (1983) 0.76

Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease. Oral Surg Oral Med Oral Pathol (1992) 0.76

Effects of phenoxymethylpenicillin, clindamycin and tinidazole on the anaerobic oral, throat and colon flora in man. Scand J Infect Dis Suppl (1980) 0.76

Beta-lactamase producing anaerobic bacteria in the oropharynx and their clinical relevance. Scand J Infect Dis Suppl (1988) 0.76

Template bleeding time for preoperative screening in patients having orthognathic surgery. Br J Oral Maxillofac Surg (2008) 0.76

Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplant (1988) 0.76

A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies. Bone Marrow Transplant (1986) 0.76

Culturing the exudate of an odontogenic infection--a useful procedure? Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 0.75

Salivary secretion in children after fractionated or single-dose TBI. Bone Marrow Transplant (2011) 0.75

[Orofacial infection. 3. Bacterial infections, therapy and prophylaxis]. Tandlakartidningen (1982) 0.75

Comparison of E test and agar dilution methods for determining antibiotic susceptibilities of anaerobic bacteria and viridans streptococci isolated from blood. Anaerobe (1998) 0.75

Comparison between two non-absorbable antibiotic regimens for decontamination of the oropharynx. Infection (1985) 0.75

[Orofacial infections. 1. The normal microflora and microbiological culturing and diagnosis]. Tandlakartidningen (1982) 0.75

Impact of phenoxymethylpenicillin, erythromycin, clindamycin and doxycycline on Streptococcus salivarius in the oropharynx. J Antimicrob Chemother (1984) 0.75

Predisposing factors for development of oral lesions after allogeneic bone marrow transplantation. Transplant Proc (1990) 0.75

[Orofacial infections. 2. Bacterial infections, clinical diagnosis]. Tandlakartidningen (1982) 0.75

Antibody response in patients with osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 0.75

Replantation of avulsed teeth after long extra-alveolar periods. Int J Oral Surg (1983) 0.75

[Orofacial infection. 4. Virus and fungus infections]. Tandlakartidningen (1982) 0.75

Streptococcus mutans major adhesion surface protein, P1 (I/II), does not contribute to attachment to valvular vegetations or to the development of endocarditis in a rat model. Arch Oral Biol (1996) 0.75

Prophylaxis with tinidazole in oral surgery. Tissue penetration and effect on the oral microflora. Int J Oral Surg (1984) 0.75

Latent bone cyst as healing artifact. A case report. Int J Oral Surg (1982) 0.75

Cardiovascular infections: bacterial endocarditis of oral origin. Pathogenesis and prophylaxis. J Clin Periodontol (1990) 0.75

Clindamycin in the upper respiratory tract infections. Scand J Infect Dis Suppl (1984) 0.75

Effect of tinidazole on the human oral microflora: a comparison between high single and low repeated doses. J Antimicrob Chemother (1982) 0.75

Bone marrow transplantation for aplastic anemia and acute leukemia at Huddinge Hospital. Scand J Urol Nephrol Suppl (1981) 0.75

[What is the treatment for acute leukemia and aplastic anemia?]. Tandlakartidningen (1984) 0.75

[Prolonged survival after bone marrow transplantation in patients older than 30 years of age]. Lakartidningen (1990) 0.75

Microbiological and clinical aspects on intraabdominal infections. Scand J Gastroenterol Suppl (1984) 0.75

Surgery in the treatment of denture-related inflammatory papillary hyperplasia of the plate. Int J Oral Surg (1980) 0.75

[A case of morpho-functional disturbance as a complication of root canal therapy]. Odontol Foren Tidskr (1969) 0.75